HIV-specific CD4 T cell responses, particularly to the envelope glycoproteins, are poor or absent in the majority of HIV-infected subjects. The reason for this specific T cell unresponsiveness remains unclear. One element of the immune response known to have the capacity to modulate specific T cell responses is antibodies (Abs). Abs forming antigen/Ab complexes can alter the uptake, processing, and/or presentation of an antigen, resulting in enhanced or suppressed T cell responses to that antigen. Recently, we showed that CD4 T cell responses to gp120 are inhibited in the presence of serum Abs from HIV+ patients, and specifically by monoclonal Abs (mAbs) to the CD4 binding domain of gp120 (gp120cmbd). Hence, the presence of anti-gp 120CD4bdAbs in the sera of HIV+ individuals may contribute to the poor gp 120-specific T cell responses seen in most infected individuals. The main objective of the proposed study is to investigate the physiological relevance of anti-gp120co4ba Abs. In this study, we will evaluate the suppressive activity of different anti-gp120coabd mAbs that have varying levels of affinity for gp120 (Aim 1). We will compare the levels and activity of anti-gp120coabd Abs in the sera of HIV+ subjects who are able to maintain HIV env-specific Th responses and in the sera of those who lack anti-env Th responses (Aim 2). Since the majority of HIV+ individuals produce anti-gpl20coabd Abs and have no detectable Th responses to env, the absence or low levels of anti-gpl20conbd Abs in unique cohorts of HIV+ subjects with env-specific Th responses would be a first indication of anti-gp120cO4bd Abs influencing env-specific Th responses in vivo. We also will evaluate the kinetics of appearance of anti-gp120Cmbd Abs early after HIV infection and after immunization with candidate HIV vaccines, and determine the relationship between these Abs with changes in Th responses to env (Aim 3). Finally, the suppressive effect of anti-gp120cD4bd Abs will be evaluated in vitro and in vivo using a mouse system, allowing us to examine more directly the physiologic role of these Abs in modulating env-specific Th responses (Aim 4). The proposed study is an essential first step to understanding the pathogenic role of Abs in HIV infection, and will provide important information for the development of more effective AIDS vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI048371-01A2
Application #
6553224
Study Section
AIDS and Related Research 8 (AARR)
Program Officer
Wassef, Nabila M
Project Start
2002-09-01
Project End
2006-02-28
Budget Start
2002-09-01
Budget End
2003-02-28
Support Year
1
Fiscal Year
2002
Total Cost
$150,430
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Weiden, Michael D; Hoshino, Satomi; Levy, David N et al. (2014) Adenosine deaminase acting on RNA-1 (ADAR1) inhibits HIV-1 replication in human alveolar macrophages. PLoS One 9:e108476
Kumar, Rajnish; Tuen, Michael; Liu, Jianping et al. (2013) Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines. Vaccine 31:5413-21
Kumar, Rajnish; Visciano, Maria Luisa; Li, Hualin et al. (2012) Targeting a Neutralizing Epitope of HIV Envelope Gp120 by Immune Complex Vaccine. J AIDS Clin Res S8:
Kumar, Rajnish; Tuen, Michael; Li, Hualin et al. (2011) Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation. Vaccine 29:9064-74
Hioe, Catarina E; Visciano, Maria Luisa; Kumar, Rajnish et al. (2009) The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120. Vaccine 28:352-60
Li, Hualin; Xu, Chong-Feng; Blais, Steven et al. (2009) Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes. J Immunol 182:6369-78
Li, Hualin; Chien Jr, Peter C; Tuen, Michael et al. (2008) Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes. J Immunol 180:4011-21
Visciano, Maria Luisa; Tuen, Michael; Gorny, Miroslaw K et al. (2008) In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120. Virology 372:409-20
Kaur, Gurvinder; Tuen, Michael; Virland, Diana et al. (2007) Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection. Virology 369:214-25